SCHEMBL19804667

SCHEMBL19804667

C=CC(=O)OCCc1cc(C2CCCCC2)ccc1-c1ccc(CO)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.43
S1PR1 P21453 5/20 0.36
S1PR5 Q9H228 4/20 0.36
S1PR3 Q99500 3/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 1/20 0.36
APP P05067 1/20 0.36
THRB P10828 1/20 0.34
ACMSD Q8TDX5 1/20 0.34
NAAA Q02083 1/20 0.34
ASAH1 Q13510 1/20 0.34
PPARG P37231 2/20 0.33
PPARA Q07869 1/20 0.33
TSHR P16473 3/20 0.33
ALDH1A1 P00352 3/20 0.33
TP53 P04637 2/20 0.33
HIF1A Q16665 2/20 0.33
HSD17B10 Q99714 1/20 0.33
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19804789 0.86 FFAR4 (0.47) FFAR4S1PR1S1PR5S1PR3CYP3A4
SCHEMBL19804642 0.84 FFAR4 (0.42) FFAR4S1PR1S1PR5S1PR3CYP3A4
SCHEMBL19804405 0.84 FFAR4 (0.40) FFAR4S1PR1S1PR5S1PR3CYP3A4
SCHEMBL19796891 0.83 THRB (0.36) FFAR4CYP2C9THRBTSHRALDH1A1
SCHEMBL19804804 0.83 FFAR4 (0.42) FFAR4CYP3A4CYP2C9APPTHRB
SCHEMBL19804579 0.83 FFAR4 (0.43) FFAR4S1PR1S1PR5S1PR3CYP3A4
SCHEMBL19804437 0.81 FFAR4 (0.38) FFAR4CYP3A4CYP2C9APPTHRB
SCHEMBL19804758 0.81 FFAR4 (0.47) FFAR4S1PR1S1PR5S1PR3CYP3A4
SCHEMBL19804596 0.81 FFAR4 (0.42) FFAR4S1PR1S1PR5S1PR3CYP3A4
SCHEMBL19804558 0.80 FFAR4 (0.43) FFAR4S1PR1S1PR5S1PR3CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 FFAR4 1715/4885S1PR1 98/4885S1PR5 131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.